A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection
NCT07154706 · RECRUITING · Phase 3
We track 1 ClinicalTrials.gov studies led by Nuvation Bio Inc. The portfolio skews toward Phase 3 (1 trials).
1 clinical trials sponsored by Nuvation Bio Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 100% |
Nuvation Bio Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.
Nuvation Bio Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Nuvation Bio Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.